Pasar al contenido principal

NUEVAS FUNCIONES DE C3G EN HEMATOPOYESIS: PAPEL EN LA RESPUESTA INMUNE MEDIADA POR PLAQUETAS, EN LA FUNCION DEL NICHO MK Y EN EL DESARROLLO DE TRASTORNOS MIELOPROLIFERATIVOS

PID2022-137717OB-C22

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2022
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DE SALAMANCA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

C3G promotes bone marrow adipocyte expansion and hematopoietic regeneration after myeloablation by enhancing megakaryocyte niche function

  • Herranz, Óscar
  • Berrocal, Pablo
  • Sicilia-Navarro, Carmen
  • Fernández-Infante, Cristina
  • Hernández-Cano, Luis
  • Porras, Almudena
  • Guerrero Arroyo, María del Carmen
C3G, a Rap1 GEF, promotes megakaryopoiesis and platelet function. Using transgenic and knock-out mouse models targeting C3G in megakaryocytes, we investigated whether C3G also affects the niche function of megakaryocytes during bone marrow (BM) recovery after myeloablation induced by 5-fluorouracil (5-FU), or total body irradiation (TBI) followed by bone marrow transplantation. C3G promoted megakaryocyte maturation and platelet production during recovery, along with increased white and red blood cell counts and enhanced survival of female mice after repeated doses of 5-FU. Additionally, megakaryocytes favored adipocyte differentiation through a C3G-mediated mechanism, likely involving Fgf1. Changes in the number or behavior of BM megakaryocytes and adipocytes influenced the hematopoietic stem cell pool, with C3G promoting its bias towards the myeloid-megakaryocytic lineage in both 5-FU- and TBI-ablated models. Therefore, C3G could be a potential target in therapies aimed at enhancing hematopoiesis in patients undergoing chemotherapy and/or BM transplantation., This work was supported by grants PID 2019-104143RB-C21 and PID2022-137717OB-C22 (CG), PID 2019-104143RB-C22 and PID2022-137717OB-C21 (AP) funded by MCIN/AEI/10.13039/501100011033 and ERDF “A way of making Europe”, and by grant SA078P20 (CG) funded by the Council of Education of Junta de Castilla y León, Spain and ERDF “A way of making Europe”. ÓH and CS-N are recipients of FPU fellowships from the Spanish Ministry of Education. PB, CF-I and LH-C are recipients of fellowships from the Council of Education of Junta de Castilla y León, Spain, and The Social European Funding. ÓH was also recipient of an EMBO Scientific Exchange Grant. The authors’ institution is supported by the Programa de Apoyo a Planes Estratégicos de Investigación de Estructuras de Investigación de Excelencia co-funded by Junta de Castilla y León and ERDF (CLC-2017–01) and by the Scientific Foundation of the Spanish Association Against Cancer (Programa Excelencia 2022 EPAEC222641CICS)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Platelet C3G protects from liver fibrosis, while enhancing tumor growth through regulation of the immune response

  • Baquero, Cristina
  • Iniesta-González, Minerva
  • Palao, Nerea
  • Fernández-Infante, Cristina
  • Cueto-Remacha, Mateo
  • Mancebo, Jaime
  • Cámara-Fuentes, Samuel de la
  • Rodrigo-Faus, María
  • Valdecantos, M. P.
  • Valverde, Ángela M.
  • Sequera, Celia
  • Manzano, Sara
  • Cuesta, Ángel M.
  • Gutiérrez-Uzquiza, Álvaro
  • Bragado, Paloma
  • Guerrero, Carmen
  • Porras, Almudena
Primary liver cancer usually occurs in the context of chronic liver disease (CLD), in association with fibrosis. Platelets have emerged as important regulators of CLD and liver cancer, although their precise function and mechanism of action need to be clarified. C3G (RapGEF1) regulates platelet activation, adhesion, and secretion. Here we evaluate the role of platelet C3G in chemically induced fibrosis and liver cancer associated with fibrosis using genetically modified mouse models. We found that while overexpression of full-length C3G in platelets decreased liver fibrosis induced by chronic treatment with CCl4, overexpressed C3G lacking the catalytic domain did not, although in both cases platelet recruitment to the liver was similar. In addition, C3G deletion in platelets (PF4-C3GKO mouse model) increased CCl4-induced liver damage and hepatic fibrosis, reducing liver platelets and macrophages. Moreover, early liver immune response to CCl4 was altered in PF4-C3GKO mice, with a remarkable lower activation of macrophages and increased monocyte-derived macrophages compared to WT mice. On the other hand, in response to DEN+CCl4, PF4-C3G WT mice exhibited more and larger liver tumors than PF4-C3GKO mice, accompanied by the presence of more platelets, despite having less fibrosis in previous steps. Liver immune cell populations were also differentially regulated in PF4-C3GKO mice, highlighting the higher number of macrophages, likely with a pro-inflammatory phenotype, present in the liver in response to chronic DEN+CCl4 treatment. Proteins upregulated or downregulated in platelet-rich plasma from PF4-C3GKO compared to WT mice might regulate the immune response and tumor development. In this regard, enrichment analyses using proteomic data showed changes in several proteins involved in platelet activation and immune response pathways. Additionally, the higher secretion of CD40L by PF4-C3GKO platelets could contribute to their antitumor effect. Therefore, platelet C3G presents antifibrotic and protumor effects in the liver, likely mediated by changes in the immune response. © 2025 The Author(s). The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland., This work was supported by grants from the Spanish Ministry of Economy and Competitiveness and Science, Innovation and Universities (PID2022-137717OB-C21 to AP/AMC; PID2019-104143RB-C22 to AP; PID2022-137717OB-C22 to CG; PID2019-104143RB-C21 to CG; PID2019-104991RB-I00 and PID2022-136959OB-I00 to PB, PID2020-117650RA-I00 and CNS2023-144109 to AG-U, PID-2021-122766OB-100 to AVM and funded by MICIU/AEI/10.13039/501100011033). All funding was cosponsored by the European ‘ERDF A way of making Europe’. CB was supported by Grant PID2019-104143RB-C22. NP was a recipient of a Formacion de Profesorado Universitario fellowship from the Spanish Ministry of Education. MI is supported by a predoctoral contract from Comunidad de Madrid. MC is a recipient of a predoctoral contract from UCM., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Deletion of C3G in hepatocytes impairs full liver maturation and alters glucose homeostasis

  • Palao, Nerea
  • Mancebo, Jaime
  • Baquero, Cristina
  • Iniesta-González, Minerva
  • Cueto-Remacha, Mateo
  • Rodrigo-Faus, María
  • Gutiérrez-Uzquiza, Álvaro
  • Bragado, Paloma
  • Cuesta, Ángel M.
  • Sánchez, Aranzazu
  • Guerrero Arroyo, María del Carmen
  • Porras, Almudena
C3G (RapGEF1) regulates the biology of liver hepatic progenitor cells and hepatocarcinoma cells, but its role in hepatocytes remained unknown. Therefore, we generated a mouse model lacking C3G in hepatocytes (C3GKOAlb), which showed liver damage as evidenced by increased fibrosis, liver macrophages and serum transaminases activity. Furthermore, impaired liver maturation was observed in C3GKOAlb mice demonstrated by the low expression of hepatocyte specific proteins (i.e. HNF4α), but higher levels of Alpha-fetoprotein, and stemness markers (i.e. CD133). Glucose homeostasis was also altered in C3GKOAlb mice, as well as insulin and glucagon effects on hepatocytes, which resulted in reduced serum glucose levels and an enhanced response to glucagon. In addition, the expression of several glycolytic and gluconeogenic enzymes, as well as the levels of the active form of Glycogen phosphorylase (PYGL), were upregulated in livers from C3GKOAlb mice, being remarkable the increased Pyruvate kinase isoform 2 (PKM2) levels accompanied by higher serum lactate concentrations. An increased expression of the ketogenic enzyme 3-hydroxy 3-methylglutaryl-CoA (HMG) synthase (Hmgcs2) was also found in these livers in parallel to elevated blood levels of beta-hydroxy-butyrate. Moreover, the fasting response was enhanced in C3GKOAlb mice as compared to wt animals. Hence, livers lacking C3G in hepatocytes showed a higher expression of gluconeogenic, lipogenic and ketogenic enzymes than livers from wt mice and enhanced ketogenesis. Mechanistically, data support a PTBP1-mediated upregulation of PKM2 expression in hepatocytes lacking C3G, which leads to enhanced glycolysis. Other metabolic alterations are likely due to the defective insulin signaling and the enhanced glucagon signaling through a cAMP-PKA-dependent mechanism. In summary, we have identified a novel role for C3G in the liver as a key mediator of hepatocyte differentiation and metabolic functions of hepatocytes. Hence, its absence leads to an immature phenotype and an altered response to insulin and glucagon, favoring glucagon actions., This work was supported by grants from the Spanish Ministry of Science, Innovation and Universities [PID2022-137717OB-C21 to AP/AMC; PID2019-104143RB-C22 to AP; PID2022-137717OB-C22 to CG; PID2019-104143RB-C21 to CG; PID2021-124830OB-I00 to AS; PID2019-104991RB-I00 and PID2022-136959OB-I00 to PB, PID2020-117650RA-I00 and CNS2023-144109 to AG-U, PID2021-124830OB-I00 to AS and funded by MICIU/AEI/10.13039/501100011033]. All funding was cosponsored by the European “ERDF A way of making Europe”. NP was a recipient of an FPU fellowship from the Spanish Ministry of Education. CB was supported by the PID2019-104143RB-C22 grant. MI-G is supported by a predoctoral contract from Comunidad de Madrid. MC-R is a recipient of a predoctoral contract from UCM and JM by the PID2022-137717OB-C21 grant., Peer reviewed
e_Buah Biblioteca Digital Universidad de Alcalá
Publicación Artículo científico (JournalArticle)

Examining the effects of the RUNX1 p.Leu43Ser variant on FPD/AML phenotypes using a CRISPR/Cas9-generated knock-in murine model

  • Marín Quilez, Ana
  • García Tuñón Llanio, Ignacio|||0000-0003-4758-2151
  • Benito Sánchez, Rocío M.
  • Ordóñez García, José Luis
  • Díaz Ajenjo, Lorena
  • Lama Villanueva, Ana
  • Guerrero Arroyo, María Carmen
  • Pérez Losada, José Luis
  • González Porras, José Ramón
  • Hernandez-Rivas, Jesus Maria
  • Rey González, Mónica del
  • Bastida Bermejo, José María
15 p., This work was supported by Fundación Mutua Madrileña (FMM, AP172142019), Sociedad Española de Trombosis y Hemostasia (SETH-FETH; Premio López Borrasca 2019, 2024 and Ayuda a Grupos de Trabajo en Patología Hemorrágica 2020–2024), Fundación Castellano Leonesa de Hematología y Hemoterapia (FUCALHH 2020), and ERDF “A way of making Europe” funded by the Council of Education of Junta de Castilla y León, Spain and ERDF “A way of making Europe”, Germline heterozygous variants in RUNX1 lead to Familial Platelet Disorder with Myeloid Leukemia Predisposition (FPD/AML). Cellular and/or animal models are helpful to uncovering the role of a variant in disease progression. Twenty-five mice per genotype (RUNX1WT/WT, RUNX1WT/L43S, RUNX1L43S/L43S), previously generated by CRISPR/Cas9, and nine sub-lethally irradiated mice per genotype were investigated. Peripheral blood (PB), bone marrow (BM), and spleen samples were analyzed by flow cytometry and histopathology. Deregulated genes were analyzed by RNA-seq in BM. An aberrant myeloid Mac1+Sca1+ckit? population in the PB, BM, and spleen of two homozygous and one heterozygous mouse was observed, as well as BM hypercellularity. No Mac1+Sca1+ckit? cells were detected in any RUNX1WT/WT mice. Moreover, the spleen of both homozygous mice showed destruction of the white/red pulp and the presence of apoptotic cells. The aberrant population was also detected in four irradiated mice, two heterozygous and two homozygous, in their PB, BM, and spleen. RNA-seq studies showed 698 genes significantly deregulated in the three non-irradiated Mac1+Sca1+ckit? mice vs. six healthy mice, highlighting the alteration of genes involved in apoptosis and DNA repair. These results indicate that the homozygous form of the variant p.Leu43Ser may contribute to the pathogenesis of aberrant cells., Instituto de Salud Carlos III, Unión Europea, Comunidad de Madrid, Fundación Mutua Madrileña, Sociedad Española de Trombosis y Hemostasia, Fundación Castellano Leonesa de Hematología y Hemoterapia, Junta de Castilla y León, Agencia Estatal de Investigación, Gerencia Regional de Salud